Immatics at Cell Therapy Manufacturing & Gene Therapy Congress (Dec 4-6) in Amsterdam, The Netherlands
Fast track cell, gene & CAR-T commercialization from concept to robust patient-centric delivery
Meet Immatics at the Cell Therapy Manufacturing & Gene Therapy Congress at the RAI in Amsterdam and discuss approaches to improve the way from the first concept to the final clinical program and commercialization of cell, gene and CAR-T research.
Tuesday, Dec 3, 2.30-3pm
Workshop 1 Afternoon Session: Clinical and Early Stage CAR T and Cell Therapy Advances – Allogeneic, Solid Tumors, Combination Therapies and Safety Switches
Off-the shelf, TCR-transduced γδ T cells for solid cancers
Presenter: Ali Mohamed, VP CMC Immatics US
Further information about 2019's Cell Therapy Manufacturing & Gene Therapy Congress here.